Cargando…

A Predictive Model for Prognosis and Therapeutic Response in Hepatocellular Carcinoma Based on a Panel of Three MED8-Related Immunomodulators

The current tumor-node-metastasis (TNM) system is limited in predicting the survival and guiding the treatment of hepatocellular carcinoma (HCC) patients since the TNM system only focuses on the anatomical factors, regardless of the intratumoral molecule heterogeneity. Besides, the landscape of intr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jin, Xiaojun, Song, Yongfei, An, Zhanglu, Wu, Shanshan, Cai, Dihui, Fu, Yin, Zhang, Chuanjing, Chen, Lichao, Tang, Wen, Zheng, Zequn, Lu, Hongsheng, Lian, Jiangfang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9086905/ https://www.ncbi.nlm.nih.gov/pubmed/35558516 http://dx.doi.org/10.3389/fonc.2022.868411

Ejemplares similares

Chronic Administration of COVID-19 Drugs Fluvoxamine and Lopinavir Shortens Action Potential Duration by Inhibiting the Human Ether‐à‐go‐go–Related Gene and Cav1.2
por: Zheng, Zequn, et al.
Publicado: (2022)

4-phenylbutyric acid re-trafficking hERG/G572R channel protein by modulating the endoplasmic reticulum stress-associated chaperones and endoplasmic reticulum-associated degradation gene
por: Tang, Wen, et al.
Publicado: (2023)

What Is the Potential for Lumacaftor as a Chemical Chaperone in Promoting hERG Trafficking?
por: Zheng, Zequn, et al.
Publicado: (2022)

Deciphering Common Long QT Syndrome Using CRISPR/Cas9 in Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes
por: Song, Yongfei, et al.
Publicado: (2022)

A causal relationship between irritability and cardiovascular diseases: a Mendelian randomization study
por: Cai, Dihui, et al.
Publicado: (2023)

Molecular Insights Into the Gating Kinetics of the Cardiac hERG Channel, Illuminated by Structure and Molecular Dynamics
por: Zequn, Zheng, et al.
Publicado: (2021)

Immunomodulation in Cutaneous T Cell Lymphoma
por: Ferranti, Martina, et al.
Publicado: (2019)

Immunomodulation Mediated by Anti-angiogenic Therapy Improves CD8 T Cell Immunity Against Experimental Glioma
por: Malo, Courtney S., et al.
Publicado: (2018)

Serum Biomarker Panel for Diagnosis and Prognosis of Pancreatic Ductal Adenocarcinomas
por: Mehta, Shreya, et al.
Publicado: (2021)

Immunomodulation of NK Cells by Ionizing Radiation
por: Chen, Jiarui, et al.
Publicado: (2020)

Off-label use of chloroquine, hydroxychloroquine, azithromycin and lopinavir/ritonavir in COVID-19 risks prolonging the QT interval by targeting the hERG channel
por: Zequn, Zheng, et al.
Publicado: (2021)

Four circadian rhythm-related genes predict incidence and prognosis in hepatocellular carcinoma
por: Wu, Zhenyu, et al.
Publicado: (2022)

Corrigendum: Serum Biomarker Panel for Diagnosis and Prognosis of Pancreatic Ductal Adenocarcinomas
por: Mehta, Shreya, et al.
Publicado: (2021)

Glioblastoma-on-a-chip construction and therapeutic applications
por: Xie, Zuorun, et al.
Publicado: (2023)

Discovery of a haptoglobin glycopeptides biomarker panel for early diagnosis of hepatocellular carcinoma
por: Kohansal-Nodehi, Mahdokht, et al.
Publicado: (2023)

Harnessing immunomodulation during DNA damage in Ewing sarcoma
por: Daley, Jessica D., et al.
Publicado: (2022)

A Pyroptosis-Related Gene Panel for Predicting the Prognosis and Immune Microenvironment of Cervical Cancer
por: Hu, Haoran, et al.
Publicado: (2022)

Amino Acid Oncometabolism and Immunomodulation of the Tumor Microenvironment in Lung Cancer
por: Fahrmann, Johannes F., et al.
Publicado: (2020)

Editorial: Cancer Cell Metabolism and Immunomodulation in the Context of Tumor Metastasis
por: Dong, Qiongzhu, et al.
Publicado: (2022)

Long Non-Coding RNA AL513318.2 as ceRNA Binding to hsa-miR-26a-5p Upregulates SLC6A8 Expression and Predicts Poor Prognosis in Non-Small Lung Cancer
por: Fan, Yongfei, et al.
Publicado: (2022)

Genetic testing and prognosis of sarcomatoid hepatocellular carcinoma patients
por: Jia, Bin, et al.
Publicado: (2023)

Corrigendum: Long Non-Coding RNA AL513318.2 as ceRNA Binding to hsa-miR-26a-5p Upregulates SLC6A8 Expression and Predicts Poor Prognosis in Non-Small Lung Cancer
por: Fan, Yongfei, et al.
Publicado: (2022)

Systematic Analysis and Identification of Dysregulated Panel lncRNAs Contributing to Poor Prognosis in Head-Neck Cancer
por: Tang, Shang-Ju, et al.
Publicado: (2021)

UHMK1 Is a Novel Marker for Personalized Prediction of Pancreatic Cancer Prognosis
por: Luo, Yiqiao, et al.
Publicado: (2022)

Role and mechanism of chaperones calreticulin and ERP57 in restoring trafficking to mutant HERG-A561V protein
por: Wu, Yujia, et al.
Publicado: (2021)

Identification and Validation of Novel Biomarkers for Diagnosis and Prognosis of Hepatocellular Carcinoma
por: Hu, Xiaoyi, et al.
Publicado: (2020)

Characterization of chromatin regulators identified prognosis and heterogeneity in hepatocellular carcinoma
por: Dai, Yin-wei, et al.
Publicado: (2022)

The expression of cuproptosis-related genes in hepatocellular carcinoma and their relationships with prognosis
por: Zhao, Xueying, et al.
Publicado: (2022)

Identification of CFHR4 associated with poor prognosis of hepatocellular carcinoma
por: Ding, Qinglin, et al.
Publicado: (2022)

Autophagy-Mediated Exosomes as Immunomodulators of Natural Killer Cells in Pancreatic Cancer Microenvironment
por: Papademetrio, Daniela L., et al.
Publicado: (2021)

Immunomodulation by probiotics and prebiotics in hepatocellular carcinoma
por: Russo, Edda, et al.
Publicado: (2022)

Effects of Perioperative Dexmedetomidine on Immunomodulation in Uterine Cancer Surgery: A Randomized, Controlled Trial
por: Cho, Jin Sun, et al.
Publicado: (2021)

Resveratrol analog, triacetylresveratrol, a potential immunomodulator of lung adenocarcinoma immunotherapy combination therapies
por: He, Jian, et al.
Publicado: (2023)

Corrigendum: Identification and Validation of Novel Biomarkers for Diagnosis and Prognosis of Hepatocellular Carcinoma
por: Hu, Xiaoyi, et al.
Publicado: (2020)

Upregulated LINC01667 Expression Is Correlated With Poor Prognosis in Hepatocellular Carcinoma
por: Zhang, Kainan, et al.
Publicado: (2021)

A Novel Five-Gene Signature for Prognosis Prediction in Hepatocellular Carcinoma
por: Su, Lisa, et al.
Publicado: (2021)

Comprehensive Analysis of Immune-Related Prognosis of TK1 in Hepatocellular Carcinoma
por: Cai, Qun, et al.
Publicado: (2022)

Associations of DDX60L With the Clinical Features and Prognosis of Hepatocellular Carcinoma
por: Ye, Ziqi, et al.
Publicado: (2022)

Hepatocellular Carcinoma Intrinsic Cell Death Regulates Immune Response and Prognosis
por: De Re, Valli, et al.
Publicado: (2022)

A pyroptosis-related gene signature for prognosis prediction in hepatocellular carcinoma
por: Chen, Yongwei, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_kcmvjkki4o0h3vltu1f85d3tu5